Professional Documents
Culture Documents
1. Title Page: should include the title, name of each author, and the
institution at which the work was performed.
Text should be centered.
DWA3, an Arabidopsis DWD protein, acts as a negative
regulator in ABA signal
transduction
*
Corresponding author, Fax: +1 203 432 3204
E-mail address: xingwang.deng@yale.edu
MS
2. Abstract: summarizes the paper in 250 words or less.
DWD proteins have been reported as substrate receptors for cullin
RING ubiquitin ligase 4 (CRL4). Upon screening T-DNA mutants of
DWD genes for abscisic acid (ABA) responses we obtained several
candidates which exhibited ABA-hypersensitivity and one was named
DWA3 (DWD hypersensitive to ABA 3). DWA3 associated with the
CRL4 components DDB1 and CUL4, indicating that DWA3 may
function as a substrate receptor for CRL4. ABA-inducible transcription
factors (ABI5 and AtMYC2) and their downstream genes were hyperinduced by ABA in dwa3. Taken together, we suggest DWA3 is a
negative regulator of ABA responses and may be involved in protein
degradation mediated by CRL4.
MS
2. Abstract: summarizes the paper in 250 words or less.
mini-papers that are often published separately
DWD proteins have been reported as substrate receptors for cullin
RING ubiquitin ligase 4 (CRL4). Upon screening T-DNA mutants of
DWD genes for abscisic acid (ABA) responses we obtained several
candidates which exhibited ABA-hypersensitivity and one was named
DWA3 (DWD hypersensitive to ABA 3). DWA3 associated with the
CRL4 components DDB1 and CUL4, indicating that DWA3 may
function as a substrate receptor for CRL4. ABA-inducible transcription
factors (ABI5 and AtMYC2) and their downstream genes were hyperinduced by ABA in dwa3. Taken together, we suggest DWA3 is a
negative regulator of ABA responses and may be involved in protein
degradation mediated by CRL4.
MS
2. Abstract: summarizes the paper in 250 words or less.
mini-papers that are often published separately
should have 1 or 2 sentences of Introduction
DWD proteins have been reported as substrate receptors for cullin
RING ubiquitin ligase 4 (CRL4). Upon screening T-DNA mutants of
DWD genes for abscisic acid (ABA) responses we obtained several
candidates which exhibited ABA-hypersensitivity and one was named
DWA3 (DWD hypersensitive to ABA 3). DWA3 associated with the
CRL4 components DDB1 and CUL4, indicating that DWA3 may
function as a substrate receptor for CRL4. ABA-inducible transcription
factors (ABI5 and AtMYC2) and their downstream genes were hyperinduced by ABA in dwa3. Taken together, we suggest DWA3 is a
negative regulator of ABA responses and may be involved in protein
degradation mediated by CRL4.
MS
2. Abstract: summarizes the paper in 250 words or less.
mini-papers that are often published separately
should have 1 or 2 sentences of Introduction
1- 2 sentences of Materials and Methods
DWD proteins have been reported as substrate receptors for cullin
RING ubiquitin ligase 4 (CRL4). Upon screening T-DNA mutants of
DWD genes for abscisic acid (ABA) responses we obtained several
candidates which exhibited ABA-hypersensitivity and one was named
DWA3 (DWD hypersensitive to ABA 3). DWA3 associated with the
CRL4 components DDB1 and CUL4, indicating that DWA3 may
function as a substrate receptor for CRL4. ABA-inducible transcription
factors (ABI5 and AtMYC2) and their downstream genes were hyperinduced by ABA in dwa3. Taken together, we suggest DWA3 is a
negative regulator of ABA responses and may be involved in protein
degradation mediated by CRL4.
MS
2. Abstract: summarizes the paper in 250 words or less.
mini-papers that are often published separately
should have 1 or 2 sentences of Introduction
1- 2 sentences of Materials and Methods
3-4 sentences of Results, including quantitative data
MS
2. Abstract: summarizes the paper in 250 words or less.
mini-papers that are often published separately
should have 1 or 2 sentences of Introduction
1- 2 sentences of Materials and Methods
3-4 sentences of Results, including quantitative data
1-2 sentences of Discussion
MS
2. Abstract: summarizes the paper in 250 words or less.
mini-papers that are often published separately
should have 1 or 2 sentences of Introduction
1- 2 sentences of Materials and Methods
3-4 sentences of Results, including quantitative data
1-2 sentences of Discussion
rarely cite references. If they do, full citation must be included.
MS
3. Introduction: explains why the experiment was done.
MS
3. Introduction: explains why the experiment was done.
provides enough detail about what was previously known to explain
what the outstanding questions are
MS
3. Introduction: explains why the experiment was done.
provides enough detail about what was previously known to explain
what the outstanding questions are
specifically states the hypothesis that was tested.
MS
3. Introduction: explains why the experiment was done.
provides enough detail about what was previously known to explain
what the outstanding questions are
specifically states the hypothesis that was tested.
I write it last, to guide readers to my results
MS
4. Materials and Methods: provide sufficient detail that another
biologist could repeat your experiment.
MS
4. Materials and Methods: provide sufficient detail that another
biologist could repeat your experiment.
list the organisms used (including the latin binomial) the names of the
reagents, procedures followed, etc
MS
4. Materials and Methods: provide sufficient detail that another
biologist could repeat your experiment.
list the organisms used (including the latin binomial) the names of the
reagents, procedures followed, etc
do not give the recipe for each reagent.
Instead, cite the reference from which the recipe was obtained.
MS
4. Materials and Methods: provide sufficient detail that another
biologist could repeat your experiment.
list the organisms used (including the latin binomial) the names of the
reagents, procedures followed, etc
do not give the recipe for each reagent.
Do cite the manufacturers of esoteric reagents or equipment
MS
4. Materials and Methods: provide sufficient detail that another
biologist could repeat your experiment.
list the organisms used (including the latin binomial) the names of the
reagents, procedures followed, etc
do not give the recipe for each reagent.
Do cite the manufacturers of esoteric reagents or equipment
Both Materials and Methods and Results should be written in the past
tense. Routine calculations are not described here, unless they are done
in an unusual way.
MS
5. Results: devote one paragraph to each figure or table
MS
5. Results: devote one paragraph to each figure or table
start with a sentence explaining the purpose of the expt
MS
5. Results: devote one paragraph to each figure or table
start with a sentence explaining the purpose of the expt
second sentence should summarize the methods
MS
5. Results: devote one paragraph to each figure or table
start with a sentence explaining the purpose of the expt
second sentence should summarize the methods
third sentence states where the results are presented
MS
5. Results: devote one paragraph to each figure or table
start with a sentence explaining the purpose of the expt
second sentence should summarize the methods
third sentence states where the results are presented
remaining sentences point out the key features.
MS
5. Results: devote one paragraph to each figure or table
start with a sentence explaining the purpose of the expt
second sentence should summarize the methods
third sentence states where the results are presented
remaining sentences point out the key features.
Results can be presented as figures or tables, which should be presented
on separate pages attached after the literature cited
MS
5. Results: devote one paragraph to each figure or table
start with a sentence explaining the purpose of the expt
second sentence should summarize the methods
third sentence states where the results are presented
remaining sentences point out the key features.
Results can be presented as figures or tables, which should be presented
on separate pages attached after the literature cited
each figure or table should have its own title and caption
MS
5. Results: devote one paragraph to each figure or table
start with a sentence explaining the purpose of the expt
second sentence should summarize the methods
third sentence states where the results are presented
remaining sentences point out the key features.
Results can be presented as figures or tables, which should be presented
on separate pages attached after the literature cited
each figure or table should have its own title and caption
caption gives sufficient information that a reader can figure out what it
is about without reading the text. i.e. summarizes M&M & identifies
panels, symbols, etc
MS
6. Discussion: one paragraph per figure or table + a global discussion at
end
MS
6. Discussion: one paragraph per figure or table + a global discussion at
end
First sentence summarizes results
MS
6. Discussion: one paragraph per figure or table + a global discussion at
end
First sentence summarizes results
Remaining sentences explain them, and may propose ways to test these
explanations
MS
6. Discussion: one paragraph per figure or table + a global discussion at
end
First sentence summarizes results
Remaining sentences explain them, and may propose ways to test these
explanations
Last paragraph discusses global implications: now that we know this,
how does it change our world?
MS
7. Literature cited: all citations listed in the text should be listed at the
end of the paper.
MS
7. Literature cited: all citations listed in the text should be listed at the
end of the paper.
Formats for citing and listing references vary among journals.
MS
7. Literature cited: all citations listed in the text should be listed at the
end of the paper.
Formats for citing and listing references vary among journals.
Use the format (Smith, 2008) in the text
MS
7. Literature cited: all citations listed in the text should be listed at the
end of the paper.
Formats for citing and listing references vary among journals.
Use the format (Smith, 2008) in the text
Use this format in the Literature Cited: Smith, E.J. (2008) BRF3
encodes a novel ubiquitin ligase. Molecular Plant 3: 345-361